Previous 10 | Next 10 |
Are These Penny Stocks On Your Watch List Right Now? What are penny stocks ? According to the U.S. Securities and Exchange Commission, these are shares of companies trading for less than $5. While many traders carry their own definition of penny stocks, this is the standard issue an...
Ampio Pharmaceuticals, Inc. to Report Annual 2020 Financial Results and Provide Corporate Business Update PR Newswire ENGLEWOOD, Colo. , Feb. 24, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the adv...
Ampio Brings New Hospitals Online in Trial for Inhalation Treatment of COVID-19 with Ampion Additional study sites will accelerate patient enrollment. Preliminary data shows Ampion improves all-cause mortality. PR Newswire ENGLEWOOD, Colo. , Feb. 23, 2021 ...
Ampio Pharmaceuticals, Inc. to Present at Upcoming Investor Conference Corporate Presentation to be Webcast on February 17, 2021 PR Newswire ENGLEWOOD, Colo. , Feb. 16, 2021 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmace...
Ampio Pharmaceuticals, Inc. is a non-revenue producing biopharmaceutical company aiming to develop immunology-based therapies for inflammatory conditions. Ampio's pipeline consists of one late-stage therapeutic ("Ampion") across six inflammatory indications. Ampion is a novel bio...
Ampio Pharma (AMPE) announced early positive data from its ongoing U.S. Phase I controlled, observer-blinded clinical trial of inhaled Ampion vs standard of care for patients with COVID-19 respiratory distress (AP-014).An independent statistical analysis revealed patients admin...
Ampio Announces Early Positive Data in Phase 1 Trial of Inhaled Ampion in COVID-19 Respiratory Distress - Subjects who received Ampion treatment required less oxygen than standard of care alone. - Subjects who received Ampion treatment were stable or had improvement on the O...
Biopharmaceutical company Ampio Pharmaceuticals (AMPE) announces that its ongoing U.S. Phase I clinical trial for inhalation treatment of COVID-19 with Ampion (AP-014) is 55% enrolled.Inhaled Ampion specifically targets inflammation in the lung and is currently being inves...
Ampio Pharmaceuticals Ongoing Phase I Clinical Trial for Inhalation Treatment of COVID-19 with Ampion is 55% Enrolled PR Newswire ENGLEWOOD, Colo. , Jan. 14, 2021 /PRNewswire/ -- Ampio Pharmaceuticals, Inc . (NYSE American: AMPE), a biopharmaceutical company ...
Ampio Pharmaceuticals (AMPE) has launched a global clinical trial for the IV formulation of its lead asset Ampion for treating COVID-19 patients including in out-patient settings. It has also provided updates on Phase I clinical trial for the inhaled formulation of the Ampion curren...
News, Short Squeeze, Breakout and More Instantly...
Ampio Pharmaceuticals Inc. Company Name:
AMPE Stock Symbol:
OTCMKTS Market:
Ampio Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Next.e.GO N.V. (EGOX) rose 94.4% to $0.07 on volume of 92,836,985 shares AGBA Group Holding Limited (AGBA) rose 46.1% to $1.505 on volume of 55,502,222 shares PROSHARES TRUST (SQQQ) rose 1.2% to $12.2099 on volume of 25,933,897 shares...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 7.2% to $0.04 on volume of 426,309,096 shares PROSHARES TRUST (SQQQ) rose 1.8% to $12.07 on volume of 171,048,374 shares AGBA Group Holding Limited (AGBA) rose 157.5% to $1.03 on volume of 121,894,6...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 73.2% to $0.0646 on volume of 191,555,690 shares AGBA Group Holding Limited (AGBA) rose 245.0% to $1.38 on volume of 41,065,125 shares TIAN RUIXIANG Holdings Ltd (TIRX) rose 135.2% to $1.14 on volum...